AD
NASDAQ · ADXN
Addex Therapeutics Ltd
Healthcare · Biotechnology
$3.04
Up+$0.04 (+1.27%)
Updated Nov 5, 2026, 5:21 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.81M
- P/E ratio
- -0.89
- Dividend yield
- 0.00%
- 52-week range
- $2.56 – $7.60
- Volume
- 5.02K
- Avg. volume
- 6.27K
Price performance · ADXN
ADXN price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
ADXN closed at $3.04 after 21 trading sessions, down 2.78% for the selected period.
- Last close
- $3.04
- Period change
- -2.78%
- Period low
- $2.65
- Period high
- $3.22
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $3.14 | $3.19 | $3.0431 | $3.0431 | 5.02K |
| Nov 3, 2026 | $3.005 | $3.005 | $3.005 | $3.005 | 1.3K |
| Nov 2, 2026 | $3.14 | $3.14 | $2.99 | $2.99 | 2.23K |
| Oct 30, 2026 | $3.08 | $3.15 | $3.065 | $3.09 | 2.63K |
| Oct 29, 2026 | $2.90 | $3.05 | $2.89 | $2.93 | 2.37K |
| Oct 28, 2026 | $2.90 | $3.00 | $2.8842 | $2.96 | 7.32K |
| Oct 27, 2026 | $2.9101 | $2.99 | $2.9101 | $2.99 | 576 |
| Oct 26, 2026 | $2.92 | $2.92 | $2.90 | $2.90 | 518 |
| Oct 23, 2026 | $3.00 | $3.00 | $2.9695 | $2.97 | 7.53K |
| Oct 22, 2026 | $3.15 | $3.15 | $2.8921 | $2.8921 | 1.39K |
| Oct 21, 2026 | $3.04 | $3.04 | $2.99 | $2.99 | 945 |
| Oct 20, 2026 | $3.00 | $3.095 | $2.96 | $3.05 | 6.22K |
| Oct 19, 2026 | $2.9501 | $3.00 | $2.89 | $2.89 | 3.46K |
| Oct 16, 2026 | $3.10 | $3.195 | $2.641 | $2.76 | 11.34K |
| Oct 15, 2026 | $3.09 | $3.2497 | $2.7501 | $3.02 | 37.47K |
| Oct 14, 2026 | $2.97 | $3.0584 | $2.6501 | $2.6501 | 5.19K |
| Oct 13, 2026 | $2.98 | $3.01 | $2.98 | $3.01 | 1.21K |
| Oct 12, 2026 | $3.08 | $3.20 | $2.97 | $3.04 | 2.67K |
| Oct 9, 2026 | $3.09 | $3.249 | $3.09 | $3.2186 | 4.51K |
| Oct 8, 2026 | $3.22 | $3.23 | $3.00 | $3.18 | 11.68K |
| Oct 7, 2026 | $3.1454 | $3.16 | $2.9773 | $3.13 | 9.4K |
Latest ADXN news
The latest Smart Investors Daily articles mentioning ADXN.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…
